论文信息 - Response Rate, Event-Free Survival (EFS), and Overall Survival (OS) in Newly-Diagnosed Acute Myeloid Leukemia (AML): U.S. Food and Drug Administration (FDA) Trial-Level and Patient-Level Analyses - 字舞流文

Response Rate, Event-Free Survival (EFS), and Overall Survival (OS) in Newly-Diagnosed Acute Myeloid Leukemia (AML): U.S. Food and Drug Administration (FDA) Trial-Level and Patient-Level Analyses

R. Pazdur | G. Blumenthal | R. Sridhara | C. Ko | A. Farrell | K. Norsworthy | A. Deisseroth | Y. Gong | Xin Gao | Y. Shen | Jiaxi Zhou